AI Verdict
ICCC has stronger fundamentals based on our AI analysis.
ICCC vs IBO Fundamental Comparison
| Metric | ICCC | IBO |
|---|---|---|
| Revenue | $27.6M | $32,000.0 |
| Net Income | $-1.0M | $-11.8M |
| Net Margin | -3.8% | -36,993.8% |
| ROE | -3.8% | -93.9% |
| ROA | -2.4% | -68.0% |
| Current Ratio | 4.26x | 0.35x |
| Debt/Equity | 0.34x | 0.00x |
| EPS | $-0.12 | $-0.38 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ICCC vs IBO: Frequently Asked Questions
Is ICCC or IBO a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), ICCC has stronger fundamentals. ICCC is rated HOLD (72% confidence) while IBO is rated STRONG SELL (95% confidence). This is not investment advice.
How does ICCC compare to IBO fundamentally?
IMMUCELL CORP /DE/ has ROE of -3.8% vs IMPACT BIOMEDICAL INC.'s -93.9%. Net margins are -3.8% vs -36,993.8% respectively.
Which stock pays higher dividends, ICCC or IBO?
ICCC has a dividend yield of N/A or no dividend while IBO has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ICCC or IBO for long term?
For long-term investing, consider that ICCC has HOLD rating with 72% confidence, while IBO has STRONG SELL rating with 95% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ICCC vs IBO?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ICCC vs IBO, the AI consensus favors ICCC based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.